Skip to main content

Day: July 16, 2025

Goosehead Insurance, Inc. to Report Second Quarter 2025 Results

WESTLAKE, Texas, July 16, 2025 (GLOBE NEWSWIRE) — Goosehead Insurance, Inc. (“Goosehead” or the “Company”) (NASDAQ: GSHD), announced today that it will report its second quarter 2025 results after the market close on Wednesday, July 23, 2025. The company will hold a conference call to discuss results at 4:30 PM ET on July 23rd. To access the call by phone, participants should go to this link (registration link), and you will be provided with the dial in details. A live webcast of the conference call will also be available on Goosehead’s investor relations website at ir.gooseheadinsurance.com. A webcast replay of the call will be available at ir.gooseheadinsurance.com for one year following the call. About GooseheadGoosehead (NASDAQ: GSHD) is a rapidly growing and innovative independent personal lines insurance agency that distributes...

Continue reading

Century Aluminum Company Announces Proposed Private Offering of $400 Million of Senior Secured Notes

CHICAGO, July 16, 2025 (GLOBE NEWSWIRE) — Century Aluminum Company (NASDAQ: CENX) (“Century”) announced today a proposed private offering of $400 million aggregate principal amount of senior secured notes due July 2032 (the “Secured Notes”) subject to market and other conditions (the “Secured Notes Offering”). Century intends to use the net proceeds from the Secured Notes Offering to refinance Century’s 7.50% Senior Secured Notes due 2028 (the “2028 Notes”), to repay borrowings under Century’s credit facilities and to pay fees and expenses relating to these transactions. The interest rate and other terms of the Secured Notes will be determined at the pricing of the Secured Notes Offering. The Secured Notes will be offered and sold to qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933 (the “Securities...

Continue reading

BioAdaptives Announces National Launch of NeuroRush™ — A Cutting-Edge Adaptogenic Nootropic for Mental Clarity, Focus, and Resilience

NeuroRush™ delivers a unique blend of adaptogens and nootropic herbs designed to enhance cognitive performance, stress response and long-term brain health, without dependency or burnout. LAS VEGAS, July 16, 2025 (GLOBE NEWSWIRE) — BioAdaptives, Inc. (OTC: BDPT), an innovator in evidence-based wellness solutions, today announced the upcoming national release of NeuroRush™, a next-generation nootropic designed to support sustained cognitive performance, mental clarity, and stress adaptability. Following strong results in targeted test markets, NeuroRush™ is scheduled for full commercial release in August/September 2025. Developed as a premium adaptogen-based formula, NeuroRush™ combines six clinically studied ingredients—including Rhodiola Rosea, Ashwagandha, Bacopa Monnieri, Panax Ginseng, and Mucuna...

Continue reading

CBIZ to Announce Second-Quarter and First-Half 2025 Results on July 30, 2025

CLEVELAND, July 16, 2025 (GLOBE NEWSWIRE) — CBIZ, Inc. (NYSE: CBZ) (the “Company”), a leading national professional services advisor, will announce its financial results for the second-quarter and first-half periods ended June 30, 2025, after markets close on Wednesday, July 30, 2025. A conference call to discuss the Company’s financial results will be hosted by CBIZ President and Chief Executive Officer Jerry Grisko and Chief Financial Officer Brad Lakhia at 5 p.m. (ET) on Wednesday, July 30, 2025. The conference call will be webcast live on the investor relations page of the CBIZ website at https://cbiz.gcs-web.com/investor-overview. An archived replay of the webcast will be available following the conclusion of the call. Investors can register at https://dpregister.com/sreg/10201105/ff7ebe5f63 to receive the dial-in number and...

Continue reading

Aptorum Group Limited and DiamiR Biosciences Enter into Definitive Merger Agreement

NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) — Aptorum Group Limited (NASDAQ: APM) (“Aptorum Group,” “Aptorum” or the “Company”), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs in oncology  and infectious diseases, and DiamiR Biosciences (“DiamiR”), a developer of proprietary innovative blood-based tests for brain health and other diseases with a CLIA licensed, CAP accredited clinical laboratory in New Haven, CT, today announced that they have entered into a definitive agreement for an all-stock merger transaction, in which DiamiR Biosciences will retain its name and become a wholly-owned subsidiary of Aptorum Group upon consummation of the merger.The combined company expects to remain listed on the Nasdaq Stock Market following the closing of the merger. Ian Huen, Aptorum’s...

Continue reading

Sezzle Named to CNBC’s World’s Top Fintech Companies 2025 Amid Record Growth

Minneapolis, MN, July 16, 2025 (GLOBE NEWSWIRE) — Sezzle Inc. (NASDAQ:SEZL) (Sezzle or Company) // – Sezzle, a leader in flexible payments and financial empowerment, has been recognized on the third edition of CNBC’s World’s Top Fintech Companies 2025. The prestigious list celebrates the most innovative and high-performing fintech companies globally. The recognition by CNBC follows a remarkable run for Sezzle. Over the past year, the company’s stock has rallied over 900%, reaching record highs and positioning Sezzle as one of 2025’s best-performing public companies. In Q1, Sezzle beat both revenue and profit expectations, driven by its high-retention subscription offerings, strong consumer engagement, and operational discipline. The Company also raised its full-year guidance, underscoring confidence in continued growth. “Being...

Continue reading

Progressive Reports June 2025 Results

MAYFIELD VILLAGE, OHIO, July 16, 2025 (GLOBE NEWSWIRE) — The Progressive Corporation (NYSE:PGR) today reported the following results for the month and quarter ended June 30, 2025:  June Quarter(millions, except per share amounts and ratios; unaudited) 2025   2024   Change 2025   2024   ChangeNet premiums written $ 6,605   $ 5,749   15 % $ 20,076   $ 17,902   12 %Net premiums earned $ 6,954   $ 5,777   20 % $ 20,310   $ 17,209   18 %Net income $ 1,124   $ 803   40 % $ 3,175   $ 1,459   118 %Per share available to common shareholders $ 1.91   $ 1.37   40 % $ 5.40   $ 2.48   118 %Total pretax net realized gains (losses) on securities $ 179   $ 22   NM   $ 387   $ (127)   (405) %Combined ratio 86.6   86.2   0.4 pts. 86.2   91.9   (5.7) pts.Average diluted equivalent common shares 588.0   587.4   0 % 587.8   587.4   0 %NM...

Continue reading

Matador Technologies Inc. Board Approves Long-Term Bitcoin Treasury Acquisition Strategy

Key HighlightsStrategic objective: develop a strategy to grow Matador’s Bitcoin treasury to position the Company to be a significant corporate BTC holder. Treasury product flywheel: balance sheet growth is reinvested into BTC-denominated product revenues. Financing readiness: Matador has filed a preliminary short-form base shelf prospectus to provide capital-raising flexibility over the next 25 months. Disciplined execution: All initiatives remain subject to market conditions, financing availability, and any additional regulatory or board approvals.TORONTO, July 16, 2025 (GLOBE NEWSWIRE) — Matador Technologies Inc. (TSXV:MATA, OTCQB:MATAF, FSE:IU3) (“Matador” or the “Company”) announces that its Board of Directors (the “Board”) has recently approved the initiation of a treasury plan to pursue the accumulation of up to 6,000...

Continue reading

VCI Global to Acquire Licensed Fund Manager in Malaysia’s Labuan Jurisdiction to Launch Regulated Bitcoin Fund

Nasdaq-listed VCIG Takes Strategic Step into Digital Asset Management with Fully Licensed Platform for Institutional Bitcoin Exposure KUALA LUMPUR, Malaysia, July 16, 2025 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ: VCIG) (“VCI Global” or the “Company”), a diversified global holding company with a strategic focus on AI & Robotics, Fintech, Cybersecurity, Capital Market Consultancy, today announced it has entered into a definitive agreement to acquire V Capital Fund Management Limited, a fund management company licensed by the Labuan Financial Services Authority (Labuan FSA). The acquisition, made at a nominal consideration, is expected to close in the third quarter of 2025, subject to customary closing conditions and regulatory approvals. This strategic acquisition grants VCI Global immediate access to a regulated asset...

Continue reading

Taboola to Announce Second Quarter 2025 Financial Results on August 6, 2025

NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) — Taboola (Nasdaq: TBLA), a global leader in delivering performance at scale for advertisers, today announced that it will release second quarter 2025 financial results on Wednesday, August 6, 2025. Management will host a conference call and webcast to discuss financial results at 8:30 a.m. ET. What: Taboola Second Quarter 2025 Financial Results Conference Call When: Wednesday, August 6, 2025 at 8:30 a.m. ET Details: Taboola’s senior management team will discuss the Company’s earnings on a call that can be accessed via webcast at https://investors.taboola.com. To access the call by phone, please go to this link to register at https://register-conf.media-server.com/register/BI66bbf11936d147898488004a728e0c4band you will be provided with dial in details. The webcast will be available...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.